<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-EOE-2663</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2663</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКИЕ СООБЩЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SHORT COMMUNICATIONS</subject></subj-group></article-categories><title-group><article-title>Влияние CFP-10/ESAT-6 секреторных протеинов на долговременную неспецифическую иммунологическую память в макрофагах мышей</article-title><trans-title-group xml:lang="en"><trans-title>Effect of CFP-10/ESAT-6 secretory proteins on long-term non-specific immunological memory in mouse macrophages</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4897-8676</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лыков</surname><given-names>А. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Lykov</surname><given-names>А. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лыков Александр Петрович – кандидат медицинских наук, старший научный сотрудник</p><p>630040, г. Новосибирск, ул. Охотская, 81a</p></bio><bio xml:lang="en"><p>Alexander P. Lykov, PhD (Medicine), Senior Research Associate</p><p>81a Okhotskaya St Novosibirsk 630040</p></bio><email xlink:type="simple">aplykov2@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3481-3793</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белогородцев</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Belogorodtsev</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белогородцев Сергей Николаевич – кандидат медицинских наук, ведущий научный сотрудник</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>PhD (Medicine), Leading Research Associate</p><p>Novosibirsk</p></bio><email xlink:type="simple">s.belogorodtsev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2724-9546</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Немкова</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Nemkova</surname><given-names>Е. К.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Немкова Елизавета Кирилловна – аспирант, младший научный сотрудник</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Postgraduate Student, Junior Research Associate</p><p>Novosibirsk</p></bio><email xlink:type="simple">elizaveta.nemkova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1776-0466</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ветлугина</surname><given-names>А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vetlugina</surname><given-names>А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ветлугина Анна – младший научный сотрудник</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Junior Research Associate</p><p>Novosibirsk</p></bio><email xlink:type="simple">morpho.peleides.1997@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5313-7594</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терехова</surname><given-names>Т. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Terekhova</surname><given-names>Т. М.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Терехова Татьяна Михайловна – аспирант, младший научный сотрудник</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Postgraduate Student, Junior Research Associate</p><p>Novosibirsk</p></bio><email xlink:type="simple">t.terekhova98@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3036-9795</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шварц</surname><given-names>Я. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Schwartz</surname><given-names>Ya. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шварц Яков Шмульевич – заместитель директора по научной работе</p><p>Новосибирск</p></bio><bio xml:lang="en"><p>Deputy Director For Scientific Work</p><p>Novosibirsk</p></bio><email xlink:type="simple">yshschwartz@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Новосибирский научно-исследовательский институт туберкулеза» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Novosibirsk Tuberculosis Research Institute</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>01</day><month>06</month><year>2023</year></pub-date><volume>25</volume><issue>3</issue><fpage>489</fpage><lpage>494</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лыков А.П., Белогородцев С.Н., Немкова Е.К., Ветлугина А., Терехова Т.М., Шварц Я.Ш., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Лыков А.П., Белогородцев С.Н., Немкова Е.К., Ветлугина А., Терехова Т.М., Шварц Я.Ш.</copyright-holder><copyright-holder xml:lang="en">Lykov А.P., Belogorodtsev S.N., Nemkova Е.К., Vetlugina А., Terekhova Т.М., Schwartz Y.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2663">https://www.mimmun.ru/mimmun/article/view/2663</self-uri><abstract><p>Клетки врожденного иммунитета (моноциты/макрофаги, NK) могут также развивать иммунную память, что означает, что эти клетки обучаются после их первой встречи с патогенами, так что они проявляют неспецифический иммунологический ответ на этот же или другой патоген. Бацилла Кальметта–Герена (БЦЖ) индуцирует во врожденных иммунных клетках неспецифическую врожденную память (тренированный иммунитет). Исследовали неспецифическую врожденную память в макрофагах мышей BALB/c в ответ на микобактерии, имеющие или не имеющие в геноме RD1 область. Мышей иммунизировали вакциной БЦЖ, на 7-й день выделяли перитонеальные макрофаги и стимулировали их бактериальным липополисахаридом, CFP-10 или ESAT-6. Кроме этого, мышей иммунизировали вакциной Mycobacterium tuberculosis уро-BCG (RD1-) и штаммом Mycobacterium tuberculosis H37Rv (RD1+) подкожно или внутривенно, на 4-й день выделяли перитонеальные макрофаги и стимулировали липополисахаридом. Альвеолярные макрофаги получали из эксплантатов легких мышей инфицированных Mycobacterium tuberculosis штамма H37Rv мышей, наращивали до конфлуэнтности 70-80% и далее стимулированы их липополисахаридом. В кондиционированной среде макрофагов исследовали уровень лактата, цитокинов и глюкозы. Показано, что перитонеальные макрофаги от мышей, праймированных вакциной БЦЖ, в ответ на CFP-6 и ESAT-10 увеличили уровень продукции IL-1b, TNFa и лактата (p &lt; 0,05). Необходимо отметить тот факт, что липополисахарид также увеличивал продукцию IL-1b, TNFa и потребление глюкозы праймированными вакциной БЦЖ перитонеальными макрофагами (p &lt; 0,05). Показано, что перитонеальные макрофаги, праймированные Уро-БЦЖ, увеличивали спонтанную продукцию IL-1b и снижали спонтанную продукцию TNFa (p &lt; 0,05). В случае праймирования макрофагов подкожным или внутривенным способом введения Mycobacterium tuberculosis штамм H37Rv по-разному влияли на продукцию цитокинов – снижали продукцию IL-1b и увеличивали TNFa и IL-10. В ответ на липополисахарид перитонеальные макрофаги увеличивали продукцию IL-1b, TNFa, IL-10 и потребление глюкозы (p &lt; 0,05). Способ праймирования макрофагов Mycobacterium tuberculosis штамм H37Rv также вел к разнонаправленному уровню продукции цитокинов. Было показано, что альвеолярные макрофаги сохраняли тренированный иммунитет, так, они продуцировали повышенные уровни IL-1b, TNFa, IL-10 (p &lt; 0,05). Таким образом, макрофаги мышей сформировали фенотип тренированного иммунитета в ответ на различные типы микобактерий, который сохраняется длительное время после первичного контакта с патогеном, в частности в альвеолярных макрофагах.</p></abstract><trans-abstract xml:lang="en"><p>Innate immune cells (monocytes/macrophages, NK) can also develop immune memory, which means that these cells are trained after their first encounter with pathogens so that they exhibit a nonspecific immunological response to the same or another pathogen. Bacilli Calmette–Gu rin (BCG) induces nonspecific innate memory (trained immunity) in innate immune cells. We examined nonspecific innate memory in macrophages of BALB/c mice in response to mycobacteria with or without the RD1 region in the genome. Mice were immunized with BCG vaccine, and peritoneal macrophages were isolated on day 7, and then stimulated with bacterial lipopolysaccharide, CFP-10, or ESAT-6. In addition, mice were immunized with Mycobacterium tuberculosis uro-BCG vaccine (RD1-) and Mycobacterium tuberculosis strain H37Rv (RD1+) subcutaneously or intravenously; peritoneal macrophages were isolated and stimulated with lipopolysaccharide on day 4. Alveolar macrophages were obtained from lung explants of mice infected with Mycobacterium tuberculosis strain H37Rv mice, were expanded to confluence 70-80% and further stimulated with lipopolysaccharide. Lactate, cytokines, and glucose levels were examined in conditioned macrophage medium. Peritoneal macrophages from mice primed with BCG vaccine were shown to increase IL-1b, TNFa, and lactate production in response to CFP-6 and ESAT-10 (p &lt; 0.05). Of note is the fact that lipopolysaccharide also increased production of IL-1b, TNFa, and also increased glucose uptake by peritoneal macrophages primed with BCG vaccine (p &lt; 0.05). Peritoneal macrophages primed with Uro-BCG were shown to increase spontaneous production of IL-1b and decrease spontaneous production of TNFa (p &lt; 0.05). When macrophages were primed by subcutaneous or intravenous administration of Mycobacterium tuberculosis strain H37Rv differentially affected cytokine production, by decreasing IL-1b production and increasing TNFa and IL-10, was observed. In response to lipopolysaccharide, peritoneal macrophages increased IL-1b, TNFa, IL-10 production and glucose consumption (p &lt; 0.05). The mode of priming of macrophages with Mycobacterium tuberculosis strain H37Rv also led to multidirectional levels of cytokine production. Alveolar macrophages were shown to retain trained immunity, as they produced elevated levels of IL-1b, TNFa, and IL-10 (p &lt; 0.05). Thus, mouse macrophages formed a trained immunity phenotype in response to different types of mycobacteria, which persists for a long time after primary contact with the pathogen, particularly in alveolar macrophages.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>вакцина БЦЖ</kwd><kwd>штаммы Mycobacterium tuberculosis</kwd><kwd>цитокины</kwd><kwd>лактат</kwd><kwd>глюкоза</kwd><kwd>оксид азота</kwd></kwd-group><kwd-group xml:lang="en"><kwd>BCG vaccine</kwd><kwd>strain of Mycobacterium tuberculosis</kwd><kwd>cytokines</kwd><kwd>lactate</kwd><kwd>glucose</kwd><kwd>NO</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Abebe F., Belay M., Legesse M., Mihret A., Franken K.S. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting. Clin. Exp. Immunol., 2017, Vol. 189, no. 2, pp. 241-249.</mixed-citation><mixed-citation xml:lang="en">Abebe F., Belay M., Legesse M., Mihret A., Franken K.S. Association of ESAT-6/CFP-10-induced IFN-γ, TNF-α and IL-10 with clinical tuberculosis: evidence from cohorts of pulmonary tuberculosis patients, household contacts and community controls in an endemic setting. Clin. Exp. Immunol., 2017, Vol. 189, no. 2, pp. 241-249.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bade P., Simonetti F., Sans S., Laboudie P., Kissane K., Chappat N., Lagrange S., Apparailly F., Roubert C., Duroux-Richard I. Integrative analysis of human macrophage inflammatory response related to Mycobacterium tuberculosis virulence. Front. Immunol., 2021, Vol. 12, 668060. doi: 10.3389/fimmu.2021.668060.</mixed-citation><mixed-citation xml:lang="en">Bade P., Simonetti F., Sans S., Laboudie P., Kissane K., Chappat N., Lagrange S., Apparailly F., Roubert C., Duroux-Richard I. Integrative analysis of human macrophage inflammatory response related to Mycobacterium tuberculosis virulence. Front. Immunol., 2021, Vol. 12, 668060. doi: 10.3389/fimmu.2021.668060.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Dissel J.T., van Soolingen D. ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii. J. Infect. Dis., 2005, Vol. 191, no. 8, pp. 1301-1310.</mixed-citation><mixed-citation xml:lang="en">Dissel J.T., van Soolingen D. ESAT-6 and CFP-10 in clinical versus environmental isolates of Mycobacterium kansasii. J. Infect. Dis., 2005, Vol. 191, no. 8, pp. 1301-1310.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Feng Y., Yang X., Liu Z., Liu Y., Su B., Ding Y., Qin L., Yang H., Zheng R., Hu Z. Continuous treatment with recombinant Mycobacterium tuberculosis CFP-10-ESAT-6 protein activated human monocyte while deactivated LPS-stimulated macrophage. Biochem. Biophys. Res. Commun., 2008, Vol. 365, no. 3, pp. 534-540.</mixed-citation><mixed-citation xml:lang="en">Feng Y., Yang X., Liu Z., Liu Y., Su B., Ding Y., Qin L., Yang H., Zheng R., Hu Z. Continuous treatment with recombinant Mycobacterium tuberculosis CFP-10-ESAT-6 protein activated human monocyte while deactivated LPS-stimulated macrophage. Biochem. Biophys. Res. Commun., 2008, Vol. 365, no. 3, pp. 534-540.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ganguly N., Giang P.H., Gupta C., Basu S.K., Siddiqui I., Salunke D.M., Sharma P. Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production. Immunol. Cell Biol., 2008, Vol. 86, no. 1, pp. 98-106.</mixed-citation><mixed-citation xml:lang="en">Ganguly N., Giang P.H., Gupta C., Basu S.K., Siddiqui I., Salunke D.M., Sharma P. Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production. Immunol. Cell Biol., 2008, Vol. 86, no. 1, pp. 98-106.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">GarcIa E.A., Blanco F.C., Muñiz X.F., Eirin M.E., Klepp L., Bigi F. Elimination of ESAT-6 and CFP-10 from a candidate vaccine against bovine tuberculosis impaired its protection efficacy in the BALBc mouse model. Int. J. Mycobacteriol., 2020, Vol. 9, no. 4, pp. 417-421.</mixed-citation><mixed-citation xml:lang="en">GarcIa E.A., Blanco F.C., Muñiz X.F., Eirin M.E., Klepp L., Bigi F. Elimination of ESAT-6 and CFP-10 from a candidate vaccine against bovine tuberculosis impaired its protection efficacy in the BALBc mouse model. Int. J. Mycobacteriol., 2020, Vol. 9, no. 4, pp. 417-421.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Guo S., Bao L., Qin Z.F., Shi X.X. (2010). The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling. Med. Microbiol. Immunol., 2010, Vol. 199, no. 2, pp. 129-137.</mixed-citation><mixed-citation xml:lang="en">Guo S., Bao L., Qin Z.F., Shi X.X. (2010). The CFP-10/ESAT-6 complex of Mycobacterium tuberculosis potentiates the activation of murine macrophages involvement of IFN-gamma signaling. Med. Microbiol. Immunol., 2010, Vol. 199, no. 2, pp. 129-137.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jungblut P.R., Schaible U.E., Mollenkopf H.J., Zimny-Arndt U., Raupach B., Mattow J., Halada P., Lamer S., Hagens K., Kaufmann S.H. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol. Microbiol., 1999, Vol. 33, no. 6, pp. 1103-1117.</mixed-citation><mixed-citation xml:lang="en">Jungblut P.R., Schaible U.E., Mollenkopf H.J., Zimny-Arndt U., Raupach B., Mattow J., Halada P., Lamer S., Hagens K., Kaufmann S.H. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: towards functional genomics of microbial pathogens. Mol. Microbiol., 1999, Vol. 33, no. 6, pp. 1103-1117.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Leem A., Y., Song J.H., Lee E.H., Lee H., Sim B., Kim S.Y., Chung K.S., Kim E.Y., Jung J.Y., Park M.S., Kim Y.S., Chang J., Kang Y.A. Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy. Sci. Rep., 2018, Vol. 8, 1159. doi: 10.1038/s41598-018-19523-7.</mixed-citation><mixed-citation xml:lang="en">Leem A., Y., Song J.H., Lee E.H., Lee H., Sim B., Kim S.Y., Chung K.S., Kim E.Y., Jung J.Y., Park M.S., Kim Y.S., Chang J., Kang Y.A. Changes in cytokine responses to TB antigens ESAT-6, CFP-10 and TB 7.7 and inflammatory markers in peripheral blood during therapy. Sci. Rep., 2018, Vol. 8, 1159. doi: 10.1038/s41598-018-19523-7.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mata E., Tarancon R., Guerrero C., Moreo E., Moreau F., Uranga S., Gomez A.B., Marinova D., Domenech M., Gonzalez-Camacho F., Monzon M., Badiola J., Dominguez-Andres J., Yuste J., Anel A., Peixoto A., Martin C., Aguilo N. Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis. Sci. Immunol., 2021, Vol. 6, no. 63, eabc2934. doi: 10.1126/sciimmunol.abc2934.</mixed-citation><mixed-citation xml:lang="en">Mata E., Tarancon R., Guerrero C., Moreo E., Moreau F., Uranga S., Gomez A.B., Marinova D., Domenech M., Gonzalez-Camacho F., Monzon M., Badiola J., Dominguez-Andres J., Yuste J., Anel A., Peixoto A., Martin C., Aguilo N. Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis. Sci. Immunol., 2021, Vol. 6, no. 63, eabc2934. doi: 10.1126/sciimmunol.abc2934.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Peña D., Rovetta A.I., Hernández del Pino R.E., Amiano N.O., Pasquinelli V., Pellegrini J.M., Tateosian N.L., Rolandelli A., Gutierrez M., Musella R.M., Palmero D.J., Gherardi M.M., Iovanna J., Chuluyan H.E., García V.E. A Mycobacterium tuberculosis dormancy antigen differentiates latently infected bacillus Calmette-Guérin-vaccinated Individuals. EBioMedicine, 2015, Vol. 3, no. 8, pp. 884-890.</mixed-citation><mixed-citation xml:lang="en">Peña D., Rovetta A.I., Hernández del Pino R.E., Amiano N.O., Pasquinelli V., Pellegrini J.M., Tateosian N.L., Rolandelli A., Gutierrez M., Musella R.M., Palmero D.J., Gherardi M.M., Iovanna J., Chuluyan H.E., García V.E. A Mycobacterium tuberculosis dormancy antigen differentiates latently infected bacillus Calmette-Guérin-vaccinated Individuals. EBioMedicine, 2015, Vol. 3, no. 8, pp. 884-890.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Rothchild A.C., Olson G.S., Nemeth J., Amon L.M., Mai D., Gold E.S., Diercks A.H., Aderem A. Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo. Sci. Immunol., 2019, Vol. 4, no. 37, eaaw6693. doi: 10.1126/sciimmunol.aaw6693.</mixed-citation><mixed-citation xml:lang="en">Rothchild A.C., Olson G.S., Nemeth J., Amon L.M., Mai D., Gold E.S., Diercks A.H., Aderem A. Alveolar macrophages generate a noncanonical NRF2-driven transcriptional response to Mycobacterium tuberculosis in vivo. Sci. Immunol., 2019, Vol. 4, no. 37, eaaw6693. doi: 10.1126/sciimmunol.aaw6693.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Seghatoleslam A., Hemmati M., Ebadat S., Movahedi B., Mostafavi-Pour Z. Macrophage immune response suppression by recombinant Mycobacterium tuberculosis antigens, the ESAT-6, CFP-10, and ESAT-6/CFP-10 fusion proteins. Iran. J. Med. Sci., 2016, Vol. 41, no. 4, pp. 296-304.</mixed-citation><mixed-citation xml:lang="en">Seghatoleslam A., Hemmati M., Ebadat S., Movahedi B., Mostafavi-Pour Z. Macrophage immune response suppression by recombinant Mycobacterium tuberculosis antigens, the ESAT-6, CFP-10, and ESAT-6/CFP-10 fusion proteins. Iran. J. Med. Sci., 2016, Vol. 41, no. 4, pp. 296-304.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vierboom M., Dijkman K., Sombroek C.C., Hofman S.O., Boot C., Vervenne R., Haanstra K.G., van der Sande M., van Emst L., Domínguez-Andrés J., Moorlag S., Kocken C., Thole J., Rodríguez E., Puente, E., Martens J., van Crevel R., Netea M.G., Aguilo N., Martin C., Verreck F. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination. Cell Rep. Med., 2021, Vol. 2, no. 1, 100185. doi: 10.1016/j.xcrm.2020.100185.</mixed-citation><mixed-citation xml:lang="en">Vierboom M., Dijkman K., Sombroek C.C., Hofman S.O., Boot C., Vervenne R., Haanstra K.G., van der Sande M., van Emst L., Domínguez-Andrés J., Moorlag S., Kocken C., Thole J., Rodríguez E., Puente, E., Martens J., van Crevel R., Netea M.G., Aguilo N., Martin C., Verreck F. Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination. Cell Rep. Med., 2021, Vol. 2, no. 1, 100185. doi: 10.1016/j.xcrm.2020.100185.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Qie Y., Zhang H., Zhu B., Xu Y., Liu W., Chen J., Wang H. PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a novel immunodominant antigen of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice. Microbiol. Immunol., 2008, Vol. 52, no. 4, pp. 224-230.</mixed-citation><mixed-citation xml:lang="en">Wang J., Qie Y., Zhang H., Zhu B., Xu Y., Liu W., Chen J., Wang H. PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a novel immunodominant antigen of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice. Microbiol. Immunol., 2008, Vol. 52, no. 4, pp. 224-230.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
